Third party mediated graft rejection despite irradiation of blood products

Intracranial haemorrhage in children with inherited bleeding disorders in the UK 2003-2015: A national cohort study.

Haemophilia : the official journal of the World Federation of Hemophilia·2018

Characteristics and outcome of patients with therapy-related acute promyelocytic leukemia front-line treated with or without arsenic trioxide.

Leukemia·2017

Expression of CD33 is a predictive factor for effect of gemtuzumab ozogamicin at different doses in adult acute myeloid leukaemia.

Leukemia·2016

A comparison of clofarabine with ara-C, each in combination with daunorubicin as induction treatment in older patients with acute myeloid leukaemia.

Leukemia·2016

Optimal induction and post-remission therapy for acute myeloid leukemia.

Leukemia supplements·2016

The HSP90 inhibitor ganetespib: A potential effective agent for Acute Myeloid Leukemia in combination with cytarabine.

Leukemia research·2015

Selinexor plus lenalidomide versus lenalidomide alone as maintenance therapy after autologous haematopoietic stem cell transplantation in newly diagnosed multiple myeloma: Results of the phase 3 ALLG MM23 (SeaLAND) trial.

British journal of haematology·2026

Carrying a crisis: The risk of a painful sickle cell crisis during pregnancy.

British journal of haematology·2026

Lenalidomide maintenance after initial immunochemotherapy in chronic lymphocytic leukaemia-Final analysis of the international phase III CLL6 RESIDUUM study of the ALLG and FILO groups.

British journal of haematology·2026

Hyperdiploid multiple myeloma: A heterogeneous entity requiring refined risk stratification-Insights from chromosome count and cytogenetic abnormalities.

British journal of haematology·2026

A phase IIa study of the anti-PD-L1 antibody avelumab in relapsed/refractory PTCL: The AVAIL-T trial.

British journal of haematology·2026

Interplay between fibroblast growth factor 9 (FGF9) and CD44 underlies 46,XY disorders of sex development in Kruppel-like factor 1 (KLF-1)-E325K-associated congenital dyserythropoietic anaemia (CDA-IV).

British journal of haematology·2026

Flow Cytometric Immune Profiling Enables Early Detection of Rejection in Islet Xenotransplantation.

Xenotransplantation·2026

Steatotic Liver Disease in Allogeneic Hematopoietic Stem Cell Transplant Recipients: A Case Series and Literature Review.

Hematology reports·2026

Donor and recipient immune programs underlying delayed graft function in kidney transplantation revealed by temporal single-cell profiling.

Kidney international·2026

Inspiratory muscle strength and post-liver transplantation outcomes: safety of measurement in the ICU ‒ an observational study.

Clinics (Sao Paulo, Brazil)·2026

Urine leukemia inhibitory factor predicts kidney function recovery in patients with acute interstitial nephritis.

JCI insight·2026

Naive T cell-depleted hematopoietic stem cell transplantation to minimize immunosuppression after solid organ transplantation: case report.

Communications medicine·2026

Related Experiment Videos

Third party mediated graft rejection despite irradiation of blood products

Related Concept Videos

Intracranial haemorrhage in children with inherited bleeding disorders in the UK 2003-2015: A national cohort study.

Characteristics and outcome of patients with therapy-related acute promyelocytic leukemia front-line treated with or without arsenic trioxide.

Expression of CD33 is a predictive factor for effect of gemtuzumab ozogamicin at different doses in adult acute myeloid leukaemia.

A comparison of clofarabine with ara-C, each in combination with daunorubicin as induction treatment in older patients with acute myeloid leukaemia.

Optimal induction and post-remission therapy for acute myeloid leukemia.

The HSP90 inhibitor ganetespib: A potential effective agent for Acute Myeloid Leukemia in combination with cytarabine.

Selinexor plus lenalidomide versus lenalidomide alone as maintenance therapy after autologous haematopoietic stem cell transplantation in newly diagnosed multiple myeloma: Results of the phase 3 ALLG MM23 (SeaLAND) trial.

Carrying a crisis: The risk of a painful sickle cell crisis during pregnancy.

Lenalidomide maintenance after initial immunochemotherapy in chronic lymphocytic leukaemia-Final analysis of the international phase III CLL6 RESIDUUM study of the ALLG and FILO groups.

Hyperdiploid multiple myeloma: A heterogeneous entity requiring refined risk stratification-Insights from chromosome count and cytogenetic abnormalities.

A phase IIa study of the anti-PD-L1 antibody avelumab in relapsed/refractory PTCL: The AVAIL-T trial.

Interplay between fibroblast growth factor 9 (FGF9) and CD44 underlies 46,XY disorders of sex development in Kruppel-like factor 1 (KLF-1)-E325K-associated congenital dyserythropoietic anaemia (CDA-IV).

Flow Cytometric Immune Profiling Enables Early Detection of Rejection in Islet Xenotransplantation.

Steatotic Liver Disease in Allogeneic Hematopoietic Stem Cell Transplant Recipients: A Case Series and Literature Review.

Donor and recipient immune programs underlying delayed graft function in kidney transplantation revealed by temporal single-cell profiling.

Inspiratory muscle strength and post-liver transplantation outcomes: safety of measurement in the ICU ‒ an observational study.

Urine leukemia inhibitory factor predicts kidney function recovery in patients with acute interstitial nephritis.

Naive T cell-depleted hematopoietic stem cell transplantation to minimize immunosuppression after solid organ transplantation: case report.

Related Experiment Videos

Third party mediated graft rejection despite irradiation of blood products

Related Concept Videos

Related Articles